Last night, ITV1 aired a documentary delving into the challenges faced by the community pharmacy sector and the effects on patients. In the lead-up to this programme airing, we and many others in the sector collaborated with the ITV Tonight team over several weeks to shed light on the profound crisis impacting English pharmacies. The
Read moreBy Chief Executive Janet Morrison Less than three weeks into 2024 it is already apparent what a critical year this will be for community pharmacies as you continue to battle for survival – including in the face of imposed Category M reductions – and get ready for the launch of Pharmacy First. Our focus remains
Read moreBy Chief Executive Janet Morrison One of my first tasks on becoming PSNC Chief Executive last year was to read the results of the 2022 Pharmacy Pressures Survey. I said at the time that these made for distressing reading, and I warned Government and the NHS that they needed to urgently step up the support
Read moreBy PSNC Chief Executive Janet Morrison Pharmacy Pressures Survey 2023: Your input truly matters It’s hard to believe it’s been a little over a year since we launched the first Pharmacy Pressures Survey. Back then we were faced with an untenable situation in community pharmacy, with everyone struggling to cope with the continuous financial and
Read moreBy Chief Executive Janet Morrison Spring is supposedly the season for new beginnings. But how are community pharmacy owners supposed to have any time or energy for that? So many businesses are in a desperate position – both financially and operationally – as the cost of living, workforce and primary care crises continue to impact
Read moreThe new FreeStyle Libre 3 Sensors recently launched by Abbott Diabetes Care Ltd have been added to the Appliances section in Part IXA of the January 2024 Drug Tariff). At the same time, the sensors have also been included in the Drugs for which Discount is Not Deducted (DND) list (Part II of the Drug Tariff).
Read moreOn the 20th November 2023, Kyowa Kirin International UK NewCo Ltd increased its list prices for the following Adcal-D3 products: Product Pack size Previous list price New list price from 20 November 2023 Adcal-D3 750mg/200unit caplets 112 £2.95 £3.54 Adcal-D3 Lemon chewable tablets 56 £3.65 £4.38 Adcal-D3 Lemon chewable tablets 112 £7.49 £8.99 Adcal-D3 chewable
Read moreWith New Year’s Day (1 January 2024) occurring in the first five days of the FP34C submission window, pharmacy owners will have an extra day, until the end of 6 January 2024, to submit their December FP34Cs using the Manage Your Service (MYS) portal and to dispatch their prescription bundle to the relevant pricing division
Read moreDepartment of Health and Social Care (DHSC) has issued a medicine supply notification for Phosphate Sandoz® (sodium dihydrogen phosphate anhydrous 1.936g) effervescent tablets. MSN/2023/121 Tier 2 – medium impact Date of issue 22nd December 2023 Phosphate Sandoz® effervescent tablets are in limited supply until late March 2024. Unlicensed supplies of sodium acid (dihydrogen) phosphate 1mmol
Read moreDepartment of Health and Social Care (DHSC) has issued a medicine supply notification for Sando-K ® (potassium chloride 600mg and potassium bicarbonate 400mg [total potassium 12mmol] effervescent tablets. MSN/2023/120 Tier 2 – medium impact Date of issue 22nd December 2023 Sando-K ® effervescent tablets are in limited supply until late February 2024. Potassium chloride 600mg
Read more
